Literature DB >> 6847607

Relations between high-affinity binding sites for L-tryptophan, diazepam, salicylate and Phenol Red on human serum albumin.

U Kragh-Hansen.   

Abstract

Binding of L-tryptophan, diazepam, salicylate and Phenol Red to defatted human serum albumin was studied by ultrafiltration at pH 7.0. All ligands bind to one high-affinity binding site with association constants of the order of 10(4)-10(5)M-1. The number of secondary binding sites was found to vary from zero to five, with association constants about 10(3)M-1. Competitive binding studies with different pairs of the ligands were performed. Binding of both ligands was determined simultaneously. L-Tryptophan and diazepam were found to compete for a common high-affinity binding site on albumin. The following combinations of ligands do not bind competitively to albumin: L-tryptophan-Phenol Red, L-tryptophan-salicylate and Phenol Red-salicylate. On the other hand, high-affinity bindings of the three ligands do not take place independently but in such a way that binding of one of the ligands results in a decrease in binding of the other ligands. The decreases in binding are reciprocal and can be accounted for by introducing a coupling constant. The magnitude of the constant is dependent on the ligands being bound. In the present study, the mutual decrease in binding was more pronounced with L-tryptophan-salicylate and Phenol Red-salicylate than with L-tryptophan-Phenol Red.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6847607      PMCID: PMC1154064          DOI: 10.1042/bj2090135

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  21 in total

1.  Interaction between salicylic acid and indomethacin in binding to human serum albumin.

Authors:  D Hultmark; K O Borg; R Elofsson; L Palmer
Journal:  Acta Pharm Suec       Date:  1975

2.  Benzodiazepines: specific competitors for the binding of L-tryptophan to human serum albumin.

Authors:  W E Müller; U Wollert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

3.  The specific binding of L-tryptophan to serum albumin.

Authors:  R H McMENAMY; J L ONCLEY
Journal:  J Biol Chem       Date:  1958-12       Impact factor: 5.157

4.  Studies on the binding of benzodiazepines to human serum albumin by circular dichroism measurements.

Authors:  T Sjödin; N Roosdorp; I Sjöholm
Journal:  Biochem Pharmacol       Date:  1976-10-01       Impact factor: 5.858

5.  Independent binding of ligands to human serum albumin.

Authors:  R Brodersen; T Sjödin; I Sjöholm
Journal:  J Biol Chem       Date:  1977-07-25       Impact factor: 5.157

6.  Binding of drugs to human serum albumin:XI. The specificity of three binding sites as studied with albumin immobilized in microparticles.

Authors:  I Sjöholm; B Ekman; A Kober; I Ljungstedt-Påhlman; B Seiving; T Sjödin
Journal:  Mol Pharmacol       Date:  1979-11       Impact factor: 4.436

Review 7.  The location of drug binding sites in human serum albumin.

Authors:  K J Fehske; W E Müller; U Wollert
Journal:  Biochem Pharmacol       Date:  1981-04-01       Impact factor: 5.858

8.  An investigation of the L-tryptophan binding site on serum albumin, using cyclic analogs and fluorescent probes.

Authors:  H Bruderlein; J Bernstein
Journal:  J Biol Chem       Date:  1979-11-25       Impact factor: 5.157

9.  Direct and indirect determination of binding constants of drug-protein complexes with microparticles.

Authors:  A Kober; B Ekman; I Sjöholm
Journal:  J Pharm Sci       Date:  1978-01       Impact factor: 3.534

10.  A highly reactive tyrosine residue as part of the indole and benzodiazepine binding site of human serum albumin.

Authors:  K J Fehske; W E Müller; U Wollert
Journal:  Biochim Biophys Acta       Date:  1979-04-25
View more
  8 in total

1.  Quantitative studies of allosteric effects by biointeraction chromatography: analysis of protein binding for low-solubility drugs.

Authors:  Jianzhong Chen; David S Hage
Journal:  Anal Chem       Date:  2006-04-15       Impact factor: 6.986

2.  Relations between high-affinity binding sites of markers for binding regions on human serum albumin.

Authors:  U Kragh-Hansen
Journal:  Biochem J       Date:  1985-02-01       Impact factor: 3.857

3.  Maleimido-proxyl as an EPR spin label for the evaluation of conformational changes of albumin.

Authors:  Aleksandra Pavićević; Jinghui Luo; Ana Popović-Bijelić; Miloš Mojović
Journal:  Eur Biophys J       Date:  2017-09-23       Impact factor: 1.733

4.  Drug-binding properties of rat alpha-foetoprotein. Specificities of the phenylbutazone-binding and warfarin-binding sites.

Authors:  F Hervé; K M Rajkowski; M T Martin; P Dessen; N Cittanova
Journal:  Biochem J       Date:  1986-10-15       Impact factor: 3.857

5.  Drug-binding properties of rat alpha 1-foetoprotein. Binding of warfarin, phenylbutazone, azapropazone, diazepam, digitoxin and cholic acid.

Authors:  F Hervé; K Rajkowski; M T Martin; P Dessen; N Cittanova
Journal:  Biochem J       Date:  1984-07-15       Impact factor: 3.857

6.  Octanoate binding to the indole- and benzodiazepine-binding region of human serum albumin.

Authors:  U Kragh-Hansen
Journal:  Biochem J       Date:  1991-02-01       Impact factor: 3.857

7.  Acetylcholinesterase reactivators (HI-6, obidoxime, trimedoxime, K027, K075, K127, K203, K282): structural evaluation of human serum albumin binding and absorption kinetics.

Authors:  Filip Zemek; Jana Karasova Zdarova; Vendula Sepsova; Kamil Kuca
Journal:  Int J Mol Sci       Date:  2013-08-02       Impact factor: 5.923

8.  Improved dialytic removal of protein-bound uraemic toxins with use of albumin binding competitors: an in vitro human whole blood study.

Authors:  Xia Tao; Stephan Thijssen; Peter Kotanko; Chih-Hu Ho; Michael Henrie; Eric Stroup; Garry Handelman
Journal:  Sci Rep       Date:  2016-03-22       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.